Rheumnow Podcast

Join RheumNow for a live recap of Day 3 of ACR Convergence 2026. 
Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice.
Panelist: 

Dr. Bella Mehta

Dr. Brian Jaros 

Dr. Henrique Dalomin 

Dr. Sheila Reyes

 

Moderator: Dr. David Liew

SGLT2 Inhibitors in Lupus Nephritis
Not Seronegative Rheumatoid Arthritis-Interstitial Lung Disease
Anti-CCP Antibody Testing on the Spot
Lessons learned from ReBioLup data in Lupus Nephritis

RA-ILD and Lung Cancer
Good News and Bad News for CCP+ at Risk for RA
Sex Differences in Psoriatic Arthritis
Drugs in Lupus Nephritis Save Kidney Function, Increase Survival
What Happens to Muscle Mass and Muscle Strength in RA
GLP-1 Agonists in Psoriatic Arthritis
Infliximab Biosimilar Switching

Biologic Response in PsA
Block the Antibody Lupus, Myositis, Scleroderma
Can GLP-1 Therapy Help PsA Beyond Losing Weight
Can we do Pulmonary Testing at Home
Fibromyalgia and Depression in Rheumatoid Arthritis
Hydroxychloroquine Blood Levels and Retinopathy Risk
JAK vs TNFi in RA Can Biomarkers Help us Choose
Menopause in RA An Under Recognized Burden
New Treatments in ILD
Rosnilimab in RA Why May it be Relatively Safe
Statins and eGFR in SLE
Four Joint Fibromyalgia Warning

Day 2 of ACR Convergence 2026. Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice. Drs. Adela Castro, Antoni Chan, Eric Dein Moderator: Dr. David Liew